首页 >
法规速递
-
Intent to Exempt Certain Unclassified Medical Devices from Premarket Notification Requirements-2026/6/5
2026-06-05查看详情 > -
国家药监局药审中心关于发布《化学合成多肽药物药学研究技术指导原则（试行）》的通告（2023年第12号）-2023/02/21
2023-02-21查看详情 > -
国家药监局 公安部 国家卫生健康委关于调整麻醉药品和精神药品目录的公告（2023年第120号）-2023/9/11
2023-09-14查看详情 > -
Communications From Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products: Questions and Answers-2025/1/6
2025-01-07查看详情 > -
Document: Recommendations on eligibility to PRIME scheme - Adopted at the CHMP meeting of 27-30 January 2025-2025/2/7
2025-02-10查看详情 > -
2025年03月17日中药品种保护受理公示-2025/3/17
2025-03-18查看详情 > -
Document: Medicinal products for human use: monthly figures - March 2025-2025/4/16
2025-04-16查看详情 > -
Document: Overview of comments received on 'Reflection paper on the application of Article 40(5) of Regulation (EU) 2019/6 for certain categories of variations' (EMA/CVMP/55240/2025)-2025/6/2
2025-06-03查看详情 > -
关于公开征求《化学仿制药参比制剂目录（第九十五批）》（征求意见稿）意见的通知-2025/7/4
2025-07-07查看详情 > -
国家药监局关于养心定悸胶囊转换为非处方药的公告（2025年第74号）-2025/8/7
2025-08-10查看详情 >
